Rifaximin ameliorates intestinal inflammation in cirrhotic patients with hepatic encephalopathy.

Rifaximin (RFX) treatment can attenuate not only hyperammonemia but also Enterococcus faecalis translocation and 10-7G values, suggesting that RFX treatment may improve intestinal inflammation and result in better overall survival.